243 related articles for article (PubMed ID: 28388861)
21. Hydrogen Sulfide in Pharmacotherapy, Beyond the Hydrogen Sulfide-Donors.
Zaorska E; Tomasova L; Koszelewski D; Ostaszewski R; Ufnal M
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32085474
[TBL] [Abstract][Full Text] [Related]
22. Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.
Fomenko I; Sklyarov A; Bondarchuk T; Biletska L; Panasyuk N; Wallace JL
Stress; 2014 Dec; 17(6):528-37. PubMed ID: 25238023
[TBL] [Abstract][Full Text] [Related]
23. The Potential of Hydrogen Sulfide Donors in Treating Cardiovascular Diseases.
Wang YZ; Ngowi EE; Wang D; Qi HW; Jing MR; Zhang YX; Cai CB; He QL; Khattak S; Khan NH; Jiang QY; Ji XY; Wu DD
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672103
[TBL] [Abstract][Full Text] [Related]
24. Hydrogen Sulfide as Potential Regulatory
Sunzini F; De Stefano S; Chimenti MS; Melino S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32053981
[TBL] [Abstract][Full Text] [Related]
25. Enhanced Analgesic Effects and Gastrointestinal Safety of a Novel, Hydrogen Sulfide-Releasing Anti-Inflammatory Drug (ATB-352): A Role for Endogenous Cannabinoids.
Costa SKPF; Muscara MN; Allain T; Dallazen J; Gonzaga L; Buret AG; Vaughan DJ; Fowler CJ; de Nucci G; Wallace JL
Antioxid Redox Signal; 2020 Nov; 33(14):1003-1009. PubMed ID: 32064887
[No Abstract] [Full Text] [Related]
26. New Therapeutic Approaches Using Hydrogen Sulfide Donors in Inflammation and Immune Response.
Li M; Mao J; Zhu Y
Antioxid Redox Signal; 2021 Aug; 35(5):341-356. PubMed ID: 33789440
[No Abstract] [Full Text] [Related]
27. Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments.
Chan MV; Wallace JL
Am J Physiol Gastrointest Liver Physiol; 2013 Oct; 305(7):G467-73. PubMed ID: 23868410
[TBL] [Abstract][Full Text] [Related]
28. Role of Hydrogen Sulfide in Systemic and Pulmonary Hypertension: Cellular Mechanisms and Therapeutic Implications.
Brampton J; Aaronson PI
Cardiovasc Hematol Agents Med Chem; 2016; 14(1):4-22. PubMed ID: 26830724
[TBL] [Abstract][Full Text] [Related]
29. Hydrogen Sulfide in Renal Physiology and Disease.
Feliers D; Lee HJ; Kasinath BS
Antioxid Redox Signal; 2016 Nov; 25(13):720-731. PubMed ID: 27005700
[TBL] [Abstract][Full Text] [Related]
30. Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology.
Sun HJ; Wu ZY; Cao L; Zhu MY; Nie XW; Huang DJ; Sun MT; Bian JS
Pharmacol Res; 2020 Sep; 159():104961. PubMed ID: 32474086
[TBL] [Abstract][Full Text] [Related]
31. Hydrogen sulfide and cardioprotection--Mechanistic insights and clinical translatability.
Salloum FN
Pharmacol Ther; 2015 Aug; 152():11-7. PubMed ID: 25913517
[TBL] [Abstract][Full Text] [Related]
32. Development of hydrogen sulfide-based therapeutics for cardiovascular disease.
Predmore BL; Lefer DJ
J Cardiovasc Transl Res; 2010 Oct; 3(5):487-98. PubMed ID: 20628909
[TBL] [Abstract][Full Text] [Related]
33. A comparative study on the anti-inflammatory effects of single oral doses of naproxen and its hydrogen sulfide (H2S)-releasing derivative ATB-346 in rats with carrageenan-induced synovitis.
Ekundi-Valentim E; Mesquita FP; Santos KT; de Paula MA; Florenzano J; Zanoni CI; Rodrigues L; de Nucci G; Teixeira SA; Ferreira HH; Wallace JL; Costa SK; Muscará MN
Med Gas Res; 2013 Nov; 3(1):24. PubMed ID: 24237604
[TBL] [Abstract][Full Text] [Related]
34. Novel Angiogenic Activity and Molecular Mechanisms of ZYZ-803, a Slow-Releasing Hydrogen Sulfide-Nitric Oxide Hybrid Molecule.
Hu Q; Wu D; Ma F; Yang S; Tan B; Xin H; Gu X; Chen X; Chen S; Mao Y; Zhu YZ
Antioxid Redox Signal; 2016 Sep; 25(8):498-514. PubMed ID: 27174595
[TBL] [Abstract][Full Text] [Related]
35. Hydrogen Sulfide in Inflammation: A Novel Mediator and Therapeutic Target.
Bhatia M; Gaddam RR
Antioxid Redox Signal; 2021 Jun; 34(17):1368-1377. PubMed ID: 33138636
[No Abstract] [Full Text] [Related]
36. [Role Ofhydrogen Sulfide on Inflammatory Immune Disorders in Cardiovascular Diseases].
Pan LL; Liu XH; Zhu YZ
Sheng Li Ke Xue Jin Zhan; 2017 Feb; 48(1):30-6. PubMed ID: 29927218
[TBL] [Abstract][Full Text] [Related]
37. NSAIDs, coxibs, CINOD and H2S-releasing NSAIDs: what lies beyond the horizon.
Fiorucci S; Santucci L; Distrutti E
Dig Liver Dis; 2007 Dec; 39(12):1043-51. PubMed ID: 17997373
[TBL] [Abstract][Full Text] [Related]
38. Atherosclerosis and the Hydrogen Sulfide Signaling Pathway - Therapeutic Approaches to Disease Prevention.
Wang ZJ; Wu J; Guo W; Zhu YZ
Cell Physiol Biochem; 2017; 42(3):859-875. PubMed ID: 28641276
[TBL] [Abstract][Full Text] [Related]
39. Using hydrogen sulfide to design and develop drugs.
Calderone V; Martelli A; Testai L; Citi V; Breschi MC
Expert Opin Drug Discov; 2016; 11(2):163-75. PubMed ID: 26593865
[TBL] [Abstract][Full Text] [Related]
40. Cyclic Sulfenyl Thiocarbamates Release Carbonyl Sulfide and Hydrogen Sulfide Independently in Thiol-Promoted Pathways.
Zhao Y; Steiger AK; Pluth MD
J Am Chem Soc; 2019 Aug; 141(34):13610-13618. PubMed ID: 31373809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
